 Cell Cycle Proteins
"Cell Cycle Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins that control the CELL DIVISION CYCLE. This family of proteins includes a wide variety of classes, including CYCLIN-DEPENDENT KINASES, mitogen-activated kinases, CYCLINS, and PHOSPHOPROTEIN PHOSPHATASES as well as their putative substrates such as chromatin-associated proteins, CYTOSKELETAL PROTEINS, and TRANSCRIPTION FACTORS.
| Descriptor ID |
D018797
|
| MeSH Number(s) |
D12.776.167
|
| Concept/Terms |
Cell Cycle Proteins- Cell Cycle Proteins
- Cell Division Cycle Proteins
- Cell-Cycle Regulatory Proteins
- Cell Cycle Regulatory Proteins
- cdc Proteins
|
Below are MeSH descriptors whose meaning is more general than "Cell Cycle Proteins".
Below are MeSH descriptors whose meaning is more specific than "Cell Cycle Proteins".
This graph shows the total number of publications written about "Cell Cycle Proteins" by people in this website by year, and whether "Cell Cycle Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 5 | 0 | 5 | | 1996 | 5 | 0 | 5 | | 1997 | 7 | 1 | 8 | | 1998 | 5 | 3 | 8 | | 1999 | 10 | 0 | 10 | | 2000 | 4 | 2 | 6 | | 2001 | 4 | 0 | 4 | | 2002 | 5 | 4 | 9 | | 2003 | 6 | 2 | 8 | | 2004 | 4 | 5 | 9 | | 2005 | 6 | 10 | 16 | | 2006 | 9 | 6 | 15 | | 2007 | 6 | 5 | 11 | | 2008 | 8 | 7 | 15 | | 2009 | 3 | 7 | 10 | | 2010 | 5 | 8 | 13 | | 2011 | 9 | 9 | 18 | | 2012 | 10 | 6 | 16 | | 2013 | 3 | 10 | 13 | | 2014 | 9 | 10 | 19 | | 2015 | 3 | 8 | 11 | | 2016 | 9 | 4 | 13 | | 2017 | 4 | 7 | 11 | | 2018 | 7 | 5 | 12 | | 2019 | 5 | 5 | 10 | | 2020 | 3 | 5 | 8 | | 2021 | 4 | 2 | 6 | | 2022 | 2 | 11 | 13 | | 2023 | 0 | 4 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Cell Cycle Proteins" by people in Profiles.
-
Armstrong C, Passanisi VJ, Ashraf HM, Spencer SL. Cyclin E/CDK2 and feedback from soluble histone protein regulate the S phase burst of histone biosynthesis. Cell Rep. 2023 07 25; 42(7):112768.
-
Arora M, Moser J, Hoffman TE, Watts LP, Min M, Musteanu M, Rong Y, Ill CR, Nangia V, Schneider J, Sanclemente M, Lapek J, Nguyen L, Niessen S, Dann S, VanArsdale T, Barbacid M, Miller N, Spencer SL. Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity. Cell. 2023 Jun 08; 186(12):2628-2643.e21.
-
Cheng ML, Huang Y, Luong N, LoPiccolo J, Nishino M, Sholl LM, Chirieac LR, Santucci AD, Rabin MS, J?nne PA, Coker S, Diamond JR, Hilton J, Shapiro GI, French CA. Exceptional Response to Bromodomain and Extraterminal Domain Inhibitor Therapy With BMS-986158 in BRD4-NUTM1 NUT Carcinoma Harboring a BRD4 Splice Site Mutation. JCO Precis Oncol. 2023 Jun; 7:e2200633.
-
Nakajima R, Deguchi R, Komori H, Zhao L, Zhou Y, Shirasawa M, Angelina A, Goto Y, Tohjo F, Nakahashi K, Nakata K, Iwanaga R, Bradford AP, Araki K, Warita T, Ohtani K. The TFDP1 gene coding for DP1, the heterodimeric partner of the transcription factor E2F, is a target of deregulated E2F. Biochem Biophys Res Commun. 2023 06 30; 663:154-162.
-
Black HH, Hanson JL, Roberts JE, Leslie SN, Campodonico W, Ebmeier CC, Holling GA, Tay JW, Matthews AM, Ung E, Lau CI, Whiteley AM. UBQLN2 restrains the domesticated retrotransposon PEG10 to maintain neuronal health in ALS. Elife. 2023 03 23; 12.
-
Szwarc MM, Guarnieri AL, Joshi M, Duc HN, Laird MC, Pandey A, Khanal S, Dohm E, Bui AK, Sullivan KD, Galbraith MD, Andrysik Z, Espinosa JM. FAM193A is a positive regulator of p53 activity. Cell Rep. 2023 03 28; 42(3):112230.
-
Haase MAB, ?lafsson G, Flores RL, Boakye-Ansah E, Zelter A, Dickinson MS, Lazar-Stefanita L, Truong DM, Asbury CL, Davis TN, Boeke JD. DASH/Dam1 complex mutants stabilize ploidy in histone-humanized yeast by weakening kinetochore-microtubule attachments. EMBO J. 2023 04 17; 42(8):e112600.
-
Fu S, Yao S, Yuan Y, Previs RA, Elias AD, Carvajal RD, George TJ, Yuan Y, Yu L, Westin SN, Xing Y, Dumbrava EE, Karp DD, Piha-Paul SA, Tsimberidou AM, Ahnert JR, Takebe N, Lu K, Keyomarsi K, Meric-Bernstam F. Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification. J Clin Oncol. 2023 03 20; 41(9):1725-1734.
-
Young KL, Fisher V, Deng X, Brody JA, Graff M, Lim E, Lin BM, Xu H, Amin N, An P, Aslibekyan S, Fohner AE, Hidalgo B, Lenzini P, Kraaij R, Medina-Gomez C, Prokic I, Rivadeneira F, Sitlani C, Tao R, van Rooij J, Zhang D, Broome JG, Buth EJ, Heavner BD, Jain D, Smith AV, Barnes K, Boorgula MP, Chavan S, Darbar D, De Andrade M, Guo X, Haessler J, Irvin MR, Kalyani RR, Kardia SLR, Kooperberg C, Kim W, Mathias RA, McDonald ML, Mitchell BD, Peyser PA, Regan EA, Redline S, Reiner AP, Rich SS, Rotter JI, Smith JA, Weiss S, Wiggins KL, Yanek LR, Arnett D, Heard-Costa NL, Leal S, Lin D, McKnight B, Province M, van Duijn CM, North KE, Cupples LA, Liu CT. Whole-exome sequence analysis of anthropometric traits illustrates challenges in identifying effects of rare genetic variants. HGG Adv. 2023 01 12; 4(1):100163.
-
Zandian M, Jang SM, Lachance C, Acharya A, Byrareddy SN, C?t? J, Kutateladze TG. Characterization of multiple interactions between the envelope E protein of SARS-CoV-2 and human BRD4. STAR Protoc. 2022 12 16; 3(4):101853.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|